A New Framework for Evaluating – and Encouraging – Industry’s IP-Sharing Activities for Global Health
BIOtech Now Rufael Seyum The Access to Medicine Foundation and BIO Ventures for Global Health (BVGH) teamed up to publish a new […]
BIOtech Now Rufael Seyum The Access to Medicine Foundation and BIO Ventures for Global Health (BVGH) teamed up to publish a new […]
BIOtech Now Connor McKoy Globalization has changed our models of disease. Emerging health threats throughout the world have the potential to impact […]
BIOtech Now Andrew Segerman It’s been 25 years since Congress created the 340B Drug Discount Program – a program designed to provide […]
BIOtech Now Andrew Segerman This week, the President’s Cancer Panel published a new report entitled “Promoting Value, Affordability, and Innovation in Cancer […]
BIOtech Now Andrew Segerman As we enter a new and exciting era of medicine, there is an important question we need to […]
BIOtech Now Ken Lisaius This week, America’s Health Insurance Plans, or AHIP, is hosting its annual health policy conference. Included in the […]
BIOtech Now Andrew Segerman The weather report shows a 50 percent chance of rain tomorrow. Should you pack an umbrella just in […]
BIOtech Now Andrew Segerman Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and abuse in America. […]
BIOtech Now Andrew Segerman Writing this morning for the Detroit Free Press, Reps. Fred Upton (R-MI) and Debbie Dingell (D-MI) reinforce the need […]
BIOtech Now George Goodno This week in Geneva three key UN agencies are meeting to address and advance their shared mission of […]
BIOtech Now Jim Greenwood Over the last decade, I’ve become increasingly conscious of maintaining my cardiovascular health, making dietary changes and keeping […]
BIOtech Now George Goodno It is an underreported fact that the time it takes for a generic medicine to come to market […]
BIOtech Now Joe Hansen This past March, BIO launched DrugCostFacts.org, an interactive web tool designed to help policymakers, members of the media and […]
BIOtech Now Andrew Segerman DNA defines who we are. And like anything else, sometimes there are mistakes – mutations in genes that […]
BIOtech Now Andrew Segerman Opioid abuse and addiction is one of the worst public health crises America has ever faced. The solution, […]
BIOtech Now Daniel Seaton Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated families and economic […]
BIOtech Now Brian Newell It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking yet another critical […]
BIOtech Now Andrew Segerman Imagine that it is 2AM and the pain is so severe that you cannot move. At this point, […]
BIOtech Now Andrew Segerman Everyday it’s a new headline. The numbers keep rising. No, we’re not talking about the latest lottery jackpot. […]
BIOtech Now Andrew Segerman In 1992, with the support of the biopharmaceutical industry, Congress created the 340B Drug Discount Program to help […]